SLN compared with ALEC: revenue, margins and what each company keeps, and the suppliers and customers both name

SLNSilence Therapeutics plc

Mkt capRevenueRevenue

ALECAlector, Inc.

Mkt capRevenueRevenue

Compare

SLNSilence Therapeutics plc

ALECAlector, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Supply-chain overlap

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only SLN 2

AZNAstraZeneca ABcustomer

—Hansoh Pharmaceuticalunlistedcustomer

Shared 0

No shared counterparties.

Only ALEC 3

ABBVAbbViecustomer

GSKGlaxoSmithKlinecustomer

—Adimabunlistedsupplier

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

SLNSilence Therapeutics plc

19.73▼−0.35%· post 19.73· delayed

Mkt cap$931.7MRevenue$422,000Q1 FY26Revenue$559,000FY25

ALECAlector, Inc.

2.08▼−8.60%· post 2.15· delayed

After hoursNov 5 '26delayed

Mkt cap$254.6MRevenue$163MQ3 FY26Revenue$21MFY25

Compare

After hoursNov 5 '26delayed

SLNSilence Therapeutics plc

ALECAlector, Inc.

19.73▼−0.35%post 19.73delayed

Price

2.08▼−8.60%post 2.15delayed

$931.7M

Mkt cap

$254.6M

Q1 FY26$422,000

Revenue

$163MQ3 FY26

FY25$559,000

Revenue

$21MFY25

SLN19.73▼−0.35%vsALEC2.08▼−8.60%After hoursNov 5 '26delayed